Researcher
Frédéric Clement
- Keywords:CORE Facilities, Vaccinology, Immunology
- Disciplines:Diagnostics, Medicinal products, Laboratory medicine, Adaptive immunology, Applied immunology, Clinical microbiology, Vaccines, General diagnostics, Vaccinology
Affiliations
- Dean's Office of the Faculty of Medicine and Health Sciences (Administrative office)
Member
From1 May 2019 → Today - Department of Diagnostic Sciences (Department)
Member
From1 Oct 2018 → 30 Apr 2019 - Department of Clinical chemistry, microbiology and immunology (Department)
Member
From1 Sep 1995 → 30 Sep 2018
Projects
1 - 2 of 2
- Facility : Patiënt-afgeleide xenograft modellen – UGent;From1 Feb 2024 → TodayFunding: BOF - research organisations
- Rapid ex-vivo detection, quantification and characterisation of cell-mediated immune responses induced by natural infection or vaccination with SARS-CoV-2 orr other pathogens.From1 Apr 2021 → 31 Mar 2023Funding: IOF - technology validation in lab
Publications
1 - 10 of 27
- Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium(2022)
Authors: Sarah Begue, Gwenn Waerlop, Bruno Salaun, Michel Janssens, Duncan Bellamy, Rebecca Jane Cox, Richard Davies, Elena Gianchecchi, Donata Medaglini, Emanuele Montomoli, et al.
- Characterization of the cell-mediated immune response to TakedaU+2019s live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic setting(2022)
Authors: Vianney Tricou, Raphael Gottardo, Michael A. Egan, Frédéric Clement, Geert Leroux-Roels, Xavier Sáez-Llorens, Astrid Borkowski, Derek Wallace, Hansi J. Dean
Pages: 1143 - 1151 - Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium(2022)
Authors: Gwenn Waerlop, Geert Leroux-Roels, Teresa Lambe, Duncan Bellamy, Donata Medaglini, Elena Pettini, Rebecca Jane Cox, Mai-Chi Trieu, Richard Davies, Geir Bredholt, et al.
- The role of cell-mediated immunity against influenza and its implications for vaccine evaluation(2022)
Authors: Yorick Janssens, Gwenn Waerlop, Frédéric Clement, Geert Leroux-Roels, Isabel Leroux-Roels
- Adjuvant-associated peripheral blood mRNA profiles and kinetics induced by the adjuvanted recombinant protein candidate tuberculosis vaccine M72/AS01 in Bacillus Calmette–Guérin-vaccinated adults(2018)
Authors: Robert A. van den Berg, Laurane De Mot, Geert Leroux-Roels, Viviane Bechtold, Frédéric Clement, Margherita Coccia, Erik Jongert, Thomas G. Evans, Paul Gillard, Robbert G. van der Most
- Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans(2017)
Authors: Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clement, Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux-Roels, Arnaud Marchant, Robert A. van den Berg, et al.
Pages: 14 - 30 - Long-term persistence of cell-mediated and humoral responses to A(H1N1)pdm09 influenza virus vaccines and the role of the AS03 adjuvant system in adults during two randomized controlled trials(2017)
Authors: Robbert G. van der Most, Frédéric Clement, Walthère Dewé, Karl Walravens, David W. Vaughn, Geert Leroux-Roels, Kathryn M. Edwards
- Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial(2016)
Authors: Geert Leroux-Roels, Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G Kremsner, Edwige Haelterman, Frédéric Clement, et al.
Pages: 16 - 27 - Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01(E) in young children(2014)
Authors: Ally Olotu, Frédéric Clement, Erik Jongert, Johan Vekemans, Patricia Njuguna, Francis M Ndungu, Kevin Marsh, Geert Leroux-Roels, Philip Bejon
- A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration(2014)
Authors: Giovanni Della Cioppa, Uwe Nicolay, Kelly Lindert, Geert Leroux-Roels, Frédéric Clement, Flora Castellino, Grazia Galli, Nicola Groth, Yotam Levin, Giuseppe Del Giudice
Pages: 1701 - 1710